https://www.selleckchem.com/pr....oducts/gsk3326595-ep
A new type A botulinum toxin (BoNT/A) preparation, JTM201 (NCBI chromosomal DNA ID CP04645, has been developed, which comprises 900-kDa complexed toxin purified from Clostridium botulinum (strain NCTC13319), but its safety and efficacy have not yet been evaluated. The purpose of this study was to evaluate the long-term efficacy and safety of JTM201 at different concentrations in comparison to another commercially available BoNT/A product, Botox® (onabotulinumtoxin A, ONA), using a mouse model. The LD50 of JTM201 was simil
Like
Comment
Share
